Localized Morphea in a Pediatric Patient Successfully Treated With Topical Ruxolitinib

Pediatric morphea is a rare disorder characterized by fibrosis of the skin and underlying structures. First-line treatment of localized, uncomplicated disease is typically with high-potency topical steroids. Literature on the treatment of localized recalcitrant disease is sparse. We report a case of biopsy-confirmed morphea in a 17-year-old female that significantly improved with topical ruxolitinib 1.5% cream and intralesional triamcinolone after treatment with clobetasol ointment failed.